BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8927043)

  • 1. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.
    Domingo JL; Gomez M; Sanchez DJ; Llobet JM; Keen CL
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):233-40. PubMed ID: 8927043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
    Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
    Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-diabetic and toxic effects of vanadium compounds.
    Srivastava AK
    Mol Cell Biochem; 2000 Mar; 206(1-2):177-82. PubMed ID: 10839208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
    Domingo JL; Gómez M
    Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiron administration minimizes the toxicity of vanadate but not its insulin mimetic properties in diabetic rats.
    Domingo JL; Gomez M; Sanchez DJ; Llobet JM; Keen CL
    Life Sci; 1992; 50(18):1311-7. PubMed ID: 1532846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review.
    Scior T; Guevara-García A; Bernard P; Do QT; Domeyer D; Laufer S
    Mini Rev Med Chem; 2005 Nov; 5(11):995-1008. PubMed ID: 16307529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of various chelating agents on urinary excretion and tissue distribution of vanadium in rats.
    Gomez M; Domingo JL; Llobet JM; Corbella J
    Toxicol Lett; 1991 Jul; 57(2):227-34. PubMed ID: 1853367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration.
    Gómez M; Domingo JL; Llobet JM; Corbella J
    J Appl Toxicol; 1991 Jun; 11(3):195-98. PubMed ID: 1918793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction.
    Zhang L; Zhang Y; Xia Q; Zhao XM; Cai HX; Li DW; Yang XD; Wang K; Xia ZL
    Food Chem Toxicol; 2008 Sep; 46(9):2996-3002. PubMed ID: 18601969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
    Yao J; Battell ML; McNeill JH
    Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tiron and its combination with nutritional supplements against vanadium intoxication in female albino rats.
    Shrivastava S; Jadon A; Shukla S
    J Toxicol Sci; 2007 May; 32(2):185-92. PubMed ID: 17538242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelating agents in the treatment of acute vanadyl sulphate intoxication in mice.
    Domingo JL; Gomez M; Llobet JM; Corbella J
    Toxicology; 1990 May; 62(2):203-11. PubMed ID: 2353359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects.
    Domingo JL
    Biol Trace Elem Res; 2002 Aug; 88(2):97-112. PubMed ID: 12296430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
    Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
    Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
    Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
    Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vanadium complexes supplementation on V, Fe, Cu, Zn, Mn, Ca and K concentration in STZ diabetic rat's spleen.
    Krośniak M; Francik R; Kowalska J; Gryboś R; Blusz M; Kwiatek WM
    Acta Pol Pharm; 2013; 70(1):71-7. PubMed ID: 23610961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative characteristics of vanadium-containing compounds, possessing insulin-like effects].
    Golubev MA; Gorodetskiĭ VK; Anis'kina AP; Tochilkin AI; Beliaeva NF
    Vopr Med Khim; 2000; 46(2):155-61. PubMed ID: 10885036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
    Cam MC; Pederson RA; Brownsey RW; McNeill JH
    Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antioxidant efficacy of vanadium-3-hydroxyflavone complex in streptozotocin-diabetic rats.
    Pillai SI; Subramanian SP; Kandaswamy M
    Chem Biol Interact; 2013 Jul; 204(2):67-74. PubMed ID: 23665085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention by sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron) of vanadium-induced behavioral toxicity in rats.
    Sanchez DJ; Colomina MT; Domingo JL; Corbella J
    Biol Trace Elem Res; 1999 Sep; 69(3):249-59. PubMed ID: 10468162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.